We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

Back to rankings

61 hedge funds and large institutions have $87.7M invested in BioTelemetry, Inc. in 2013 Q2 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $983K | Put options by funds: $574K

Holders
61
Holders Change
+61
Holders Change %
–
% of All Funds
1.98%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
61
Increased
–
Reduced
–
Closed
–
Calls
$983K
Puts
$574K
Net Calls
+$409K
Net Calls Change
+$409K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

BEAT Hedge Fund Activity: Q2 2013 in Review

61 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q2 2013, worth a combined $87.7M.

Buyers outnumbered sellers: 61 funds opened new BEAT positions and 0 closed out — a net gain of 61 holders — while 0 added to existing stakes and 0 trimmed.

  • 61 institutional investors held BioTelemetry, Inc. (BEAT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $87.7M of BioTelemetry, Inc. stock for Q2 2013.
  • 61 funds opened new BioTelemetry, Inc. positions in Q2 2013 and 0 closed out, a net change of +61 holders.

Based on aggregated 13F filings for Q2 2013.